ArticleBMC medicine2026

SGLT-2 Inhibitor use and liver-related and mortality outcomes in patients with type 2 diabetes and compensated cirrhosis.

Tien-Shin Chou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.